Selected research
Industry Growth & Trends
Global Anti-Infectives Industry Growth and Trends Forecast to 2032
Market perspective
The global Anti-Infectives market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Infectives is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Infectives include Astra Zeneca plc, Glaxo SmithKline plc, Novartis, Wockhardt ltd, Pfizer, Roche, Merck, Johnson & Johnson and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Anti-Infectives market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Anti-Infectives market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Anti-Infectives market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Anti-Infectives.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Anti-Infectives market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Anti-Infectives Market by Company
Astra Zeneca plc
Glaxo SmithKline plc
Novartis
Wockhardt ltd
Pfizer
Roche
Merck
Johnson & Johnson
Sanofi
Anti-Infectives Segment by Type
Antifungal
Antibacterial
Antiviral
Anti-Infectives Segment by Application
Retail Pharmacies
Mail Order Pharmacies
Hospital Pharmacies
Anti-Infectives Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Infectives market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Infectives and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Infectives.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Anti-Infectives manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Anti-Infectives in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Antifungal
- Antibacterial
- Antiviral
Applications
- Retail Pharmacies
- Mail Order Pharmacies
- Hospital Pharmacies
Companies covered
- Astra Zeneca plc
- Glaxo SmithKline plc
- Novartis
- Wockhardt ltd
- Pfizer
- Roche
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Anti-Infectives Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Anti-Infectives Sales Estimates and Forecasts (2021-2032)
- 1.3 Anti-Infectives Market by Type
- 1.3.1 Antifungal
- 1.3.2 Antibacterial
- 1.3.3 Antiviral
- 1.4 Global Anti-Infectives Market Size by Type
- 1.4.1 Global Anti-Infectives Market Size Overview by Type (2021-2032)
- 1.4.2 Global Anti-Infectives Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Anti-Infectives Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Anti-Infectives Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Anti-Infectives Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Anti-Infectives Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Anti-Infectives Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Anti-Infectives Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Anti-Infectives Industry Trends
- 2.2 Anti-Infectives Industry Drivers
- 2.3 Anti-Infectives Industry Opportunities and Challenges
- 2.4 Anti-Infectives Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Anti-Infectives Revenue (2021-2026)
- 3.2 Global Top Players by Anti-Infectives Sales (2021-2026)
- 3.3 Global Top Players by Anti-Infectives Price (2021-2026)
- 3.4 Global Anti-Infectives Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Anti-Infectives Major Company Production Sites & Headquarters
- 3.6 Global Anti-Infectives Company, Product Type & Application
- 3.7 Global Anti-Infectives Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Anti-Infectives Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Anti-Infectives Players Market Share by Revenue in 2025
- 3.8.3 2025 Anti-Infectives Tier 1, Tier 2, and Tier 3
4 Anti-Infectives Regional Status and Outlook
- 4.1 Global Anti-Infectives Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Anti-Infectives Historic Market Size by Region
- 4.2.1 Global Anti-Infectives Sales in Volume by Region (2021-2026)
- 4.2.2 Global Anti-Infectives Sales in Value by Region (2021-2026)
- 4.2.3 Global Anti-Infectives Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Anti-Infectives Forecasted Market Size by Region
- 4.3.1 Global Anti-Infectives Sales in Volume by Region (2027-2032)
- 4.3.2 Global Anti-Infectives Sales in Value by Region (2027-2032)
- 4.3.3 Global Anti-Infectives Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Anti-Infectives by Application
- 5.1 Anti-Infectives Market by Application
- 5.1.1 Retail Pharmacies
- 5.1.2 Mail Order Pharmacies
- 5.1.3 Hospital Pharmacies
- 5.2 Global Anti-Infectives Market Size by Application
- 5.2.1 Global Anti-Infectives Market Size Overview by Application (2021-2032)
- 5.2.2 Global Anti-Infectives Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Anti-Infectives Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Anti-Infectives Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Anti-Infectives Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Anti-Infectives Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Anti-Infectives Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Anti-Infectives Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Astra Zeneca plc
- 6.1.1 Astra Zeneca plc Company Information
- 6.1.2 Astra Zeneca plc Business Overview
- 6.1.3 Astra Zeneca plc Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Astra Zeneca plc Anti-Infectives Product Portfolio
- 6.1.5 Astra Zeneca plc Recent Developments
- 6.2 Glaxo SmithKline plc
- 6.2.1 Glaxo SmithKline plc Company Information
- 6.2.2 Glaxo SmithKline plc Business Overview
- 6.2.3 Glaxo SmithKline plc Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Glaxo SmithKline plc Anti-Infectives Product Portfolio
- 6.2.5 Glaxo SmithKline plc Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Anti-Infectives Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Wockhardt ltd
- 6.4.1 Wockhardt ltd Company Information
- 6.4.2 Wockhardt ltd Business Overview
- 6.4.3 Wockhardt ltd Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Wockhardt ltd Anti-Infectives Product Portfolio
- 6.4.5 Wockhardt ltd Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Pfizer Anti-Infectives Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 Roche
- 6.6.1 Roche Company Information
- 6.6.2 Roche Business Overview
- 6.6.3 Roche Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Roche Anti-Infectives Product Portfolio
- 6.6.5 Roche Recent Developments
- 6.7 Merck
- 6.7.1 Merck Company Information
- 6.7.2 Merck Business Overview
- 6.7.3 Merck Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Merck Anti-Infectives Product Portfolio
- 6.7.5 Merck Recent Developments
- 6.8 Johnson & Johnson
- 6.8.1 Johnson & Johnson Company Information
- 6.8.2 Johnson & Johnson Business Overview
- 6.8.3 Johnson & Johnson Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Johnson & Johnson Anti-Infectives Product Portfolio
- 6.8.5 Johnson & Johnson Recent Developments
- 6.9 Sanofi
- 6.9.1 Sanofi Company Information
- 6.9.2 Sanofi Business Overview
- 6.9.3 Sanofi Anti-Infectives Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Sanofi Anti-Infectives Product Portfolio
- 6.9.5 Sanofi Recent Developments
7 North America by Country
- 7.1 North America Anti-Infectives Sales by Country
- 7.1.1 North America Anti-Infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Anti-Infectives Sales by Country (2021-2026)
- 7.1.3 North America Anti-Infectives Sales Forecast by Country (2027-2032)
- 7.2 North America Anti-Infectives Market Size by Country
- 7.2.1 North America Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Anti-Infectives Market Size by Country (2021-2026)
- 7.2.3 North America Anti-Infectives Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Anti-Infectives Sales by Country
- 8.1.1 Europe Anti-Infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Anti-Infectives Sales by Country (2021-2026)
- 8.1.3 Europe Anti-Infectives Sales Forecast by Country (2027-2032)
- 8.2 Europe Anti-Infectives Market Size by Country
- 8.2.1 Europe Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Anti-Infectives Market Size by Country (2021-2026)
- 8.2.3 Europe Anti-Infectives Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Anti-Infectives Sales by Country
- 9.1.1 Asia-Pacific Anti-Infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Anti-Infectives Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Anti-Infectives Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Anti-Infectives Market Size by Country
- 9.2.1 Asia-Pacific Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Anti-Infectives Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Anti-Infectives Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Anti-Infectives Sales by Country
- 10.1.1 South America Anti-Infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Anti-Infectives Sales by Country (2021-2026)
- 10.1.3 South America Anti-Infectives Sales Forecast by Country (2027-2032)
- 10.2 South America Anti-Infectives Market Size by Country
- 10.2.1 South America Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Anti-Infectives Market Size by Country (2021-2026)
- 10.2.3 South America Anti-Infectives Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Anti-Infectives Sales by Country
- 11.1.1 Middle East and Africa Anti-Infectives Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Anti-Infectives Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Anti-Infectives Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Anti-Infectives Market Size by Country
- 11.2.1 Middle East and Africa Anti-Infectives Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Anti-Infectives Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Anti-Infectives Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Anti-Infectives Value Chain Analysis
- 12.1.1 Anti-Infectives Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Anti-Infectives Production Mode & Process
- 12.2 Anti-Infectives Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Anti-Infectives Distributors
- 12.2.3 Anti-Infectives Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst